For press requests, please contact Jimmy Wyderko at jwyderko@economicliberties.us or 301-221-7778.


Economic Liberties Lays Out a Roadmap for 118th Congress to Rein In Corporate Power

March 24, 2023 — The American Economic Liberties Project today released a new policy agenda for antimonopoly advocates in the 118th Congress to rein in corporate power and shift our country to a fairer economy. The agenda includes a series of legislative ideas and policy proposals across sectors, recommendations for congressional investigations, and other tools for legislators looking to fight back against concentrated corporate power. 

Senate Commerce Engages in Key Debate Around Harms of Airline Deregulation and Consolidation

March 23, 2023 — The nation’s airline industry is broken,” explained American Economic Liberties Project Senior Fellow William J. McGee in testimony before the Senate Commerce Committee this morning. “It has found us all lurching from crisis to crisis, meltdown to meltdown, as the interests of consumers, workers, and entire regions of the country are subjugated to the interests of a handful of institutional investors, lobbyists, and senior executives.”

Second Circuit Rejects Baseless CFPB Attack

March 23, 2023 — In response to a decision by the United States Court of Appeals for the Second Circuit affirming the constitutionality of the Consumer Financial Protection Bureau’s independent funding through the Federal Reserve, the American Economic Liberties Project released the following statement.

Standing Up for Consumers, FTC Takes on Subscription Traps and Scams

March 23, 2023 — In response to a new proposed rule announced by the Federal Trade Commission today to prevent subscription services that make it difficult for consumers to unsubscribe from services or halt recurring payments, the American Economic Liberties Project released the following statement.

The Cure’s Fight Against Junk Fees Exposes the Harms of Ticketmaster’s Monopoly Power

March 17, 2023 — Following outrage over Ticketmaster charging additional fees on tickets for The Cure’s U.S. concert tour — sometimes more than 100% of the original price — with lead singer Robert Smith calling the practice “sickening,” the Break Up Ticketmaster Coalition released the following statement.